2019
DOI: 10.31788/rjc.2019.1245375
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis and Antibacterial Activity of 3-(2-(5- Amino-1h-Pyrazol-4-Yl) Thiazol-4-Yl)-2h-Chromen2-One and Its Derivatives

Abstract: A simple and convenient method for the preparation of 3-(2-(5-amino-1H-pyrazole-4-yl)thiazol-4-yl)-2H-chromene-2-one and 3-(2-(5-amino-3-methyl-1H-pyrazole-4-yl)thiazol-4-yl)-2H-chromene-2-ones (3a-f and 5a-f) have been prepared in good yields. The compounds have been synthesized from 2-(4-(2-oxo-2H-chromene-3-yl)thiazol-2yl)acetonitrile (1a-f), with DMF-DMA, DMA-DMA and hydrazine hydrochloride in ethanol resulted in the formation of title compounds. In this regard the whole compounds were tested for promising… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 16 publications
0
1
0
Order By: Relevance
“…The thiazole‐tethered coumarin–pyrazole hybrids 14 (inhibition zone: 10–20 mm at 100 µg/ml) showed potential activity against S. aureus , B. subtilis , E. coli , and Salmonella paratyphoid ( S. paratyphi b ), and the activity of hybrids 14a,b (inhibition zone: 20 mm at 100 µg/ml) was equal to that of ciprofloxacin (inhibition zone: 20 mm at 100 µg/ml) against Gram‐positive S. aureus and B. subtilis . [ 53 ] The majority of hybrids 15 (MIC: > 250 µg/ml) were devoid of activity against E. coli , S. aureus , E. faecalis , Vibrio cholera ( V. cholera ), and Streptococcus pyogenes ( S. pyogenes ), whereas hybrids 15a,b (MIC: 15.67–31.25 µg/ml) were superior to kanamycin (MIC: 31.25 and 62.50 µg/ml) against S. aureus and S. pyogenes . [ 54 ] Moreover, these two hybrids also displayed excellent antimicrobial activity and synergistic effects when used together with kanamycin and amphotericin B.…”
Section: Coumarin–pyrazole Hybridsmentioning
confidence: 99%
“…The thiazole‐tethered coumarin–pyrazole hybrids 14 (inhibition zone: 10–20 mm at 100 µg/ml) showed potential activity against S. aureus , B. subtilis , E. coli , and Salmonella paratyphoid ( S. paratyphi b ), and the activity of hybrids 14a,b (inhibition zone: 20 mm at 100 µg/ml) was equal to that of ciprofloxacin (inhibition zone: 20 mm at 100 µg/ml) against Gram‐positive S. aureus and B. subtilis . [ 53 ] The majority of hybrids 15 (MIC: > 250 µg/ml) were devoid of activity against E. coli , S. aureus , E. faecalis , Vibrio cholera ( V. cholera ), and Streptococcus pyogenes ( S. pyogenes ), whereas hybrids 15a,b (MIC: 15.67–31.25 µg/ml) were superior to kanamycin (MIC: 31.25 and 62.50 µg/ml) against S. aureus and S. pyogenes . [ 54 ] Moreover, these two hybrids also displayed excellent antimicrobial activity and synergistic effects when used together with kanamycin and amphotericin B.…”
Section: Coumarin–pyrazole Hybridsmentioning
confidence: 99%